Benign Prostatic Hyperplasia (BPH) Procedures

1
Benign Prostatic Hyperplasia (BPH) Procedures to
Grow at a CAGR of 2.3 by 2023
2
Benign Prostatic Hyperplasia (BPH) Procedures
Browse Detailed Summary on Benign prostatic
Hyperplasia (BPH) Procedures by Type (Surgical
Procedure, Laser Based Procedure), by End User
(Hospitals, Specialty Clinics, Ambulatory Surgery
Centers) - Global Procedures, Developments,
Growth and Forecast, 2013-2023 at
https//www.psmarketresearch.com/market-analysis/b
enign-prostatic-hyperplasia-procedures
3
Benign Prostatic Hyperplasia (BPH) Procedures
Increasing prevalence of BPH disorders to drive
the global BPH procedures
Increasing life expectancy and fall in the birth
rates are the major reasons for rise in the aging
population. The people in this category require
extensive care, since they are more prone to
illness due to low immunity levels and longer
recovery time. Increase in the aging population
in the U.S., Germany, China and India in the next
few years, is expected to create high demand for
BPH treatment devices, since the population aged
50 years and above is more prone to BPH, and
therefore tend to opt for various treatments that
involve the use of procedures such as TURP,
prostate implants and laser based treatments.
Thus, growing aging population acts as a strong
driver supporting the increase in the number of
BPH procedures performed. According to the
National Institute of Health, it has been
estimated that around 14 million men in the U.S.
had symptoms suggestive of BPH, which can affect
50 of men aged between 51 and 60 years of age,
and up to 90 of men aged more than 80 years.
With 50 of men getting affected with BPH, there
is a consequent increase in the BPH procedures.
4
Benign Prostatic Hyperplasia (BPH) Procedures
Insights on procedure segments
As per the findings of the research, surgical
procedure held the largest share in the global
BPH procedures, primarily due to increasing
prevalence of BPH disorders. The number of laser
based procedure is expected to register fastest
growth during the forecast period since these
procedures are as effective as surgical
procedures and reduce the hospital stay time.
Hospitals held the largest share of the number of
BPH procedures performed, based on the end user.
Ambulatory surgical centers are expected to
witness the highest inflow of BPH patients for
treatment during the forecast period, due to
development of technologically advanced BPH
procedures and rising prevalence of BPH disorders
leading to the growth in the number of patients
treated in the ambulatory surgical centers.
5
Benign Prostatic Hyperplasia (BPH) Procedures
Europe accounts for largest number of BPH
procedures
Geographically, Europe accounted for the largest
number of BPH procedures done in 2016. Growing
ageing population, lower cost of BPH treatment as
compared to the U.S., high healthcare spending,
and technological advancements in the field of
urological procedures technology are some of the
factors driving the growth of the BPH procedures
in the Europe. France, Germany and the U.K. are
expected to be the most promising countries for
the growth in number of the BPH procedures. In
June 2016, National Institute of Health and Care
Excellence (NICE) approved GreenLight XPS laser
treatment for the treatment of BPH. NICE added
that the widespread adoption of the procedure
could save the National Health Services (NHS) an
estimated 4.3 million (3 million) a year.
Asia-Pacific is expected to witness the high
number of BPH procedures performed during the
forecast period, owing to the rising prevalence
of BPH disorders, increasing disposable income,
aging population, and growing efforts to increase
awareness about advanced BPH treatment procedures.
6
Benign Prostatic Hyperplasia (BPH) Procedures
High number of outpatient procedures leading to
technological advancements in the BPH treatment
is a key trend in BPH procedures
There has been an increase in the use of
minimally invasive procedures such as TUIP, laser
based treatments, due to which several
technological advancements are being done in the
field of urology. Various treatment methods, such
as the use of Rezum system and pulsed
electromagnetic field therapy (PEMF), are being
developed for the treatment of BPH. Rezum system
manufactured by NxThera is a device that utilizes
radiofrequency energy to create thermal energy in
the form of water vapor to destroy excessive
prostatic tissue growth caused by BPH, to resolve
patient symptoms through a minimally invasive
procedure, with few or no side effects. Additional
ly, another example of technologically advanced
BPH treatment devices include Dr Allens device
for prostate care and ProVerum, which is used to
restore function of the urethra in BPH to allow
patients with this condition to urinate normally,
relieving their symptoms while not interfering
with sexual function. Dr Allens device uses
thermobalancing therapy, which is different from
other heating treatments as it does not regulate
localized temperature.
7
Benign Prostatic Hyperplasia (BPH) Procedures
Key players are launching new products for BPH
treatment procedures
Key players are in the process of introducing new
advanced products for BPH treatment procedures.
For instance, in May 2016, Olympus Corporation
(Olympus), announced the launch of USFDA cleared
Plasma-OvalButton, an addition to the companys
Plasma Loops and electrodes product portfolio
that utilizes Olympus plasma technology for
urologic procedures, including minimally invasive
surgery to reduce benign prostate hyperplasia
(BPH). In March 2016, Lumenis Ltd. (Lumenis),
announced the expansion of its comprehensive
Urology portfolio with the launch of Lumenis
Pulse 30H, at the European Association of Urology
Congress, in Munich. Some of the other key
players operating in the global BPH procedures
include NxThera, Inc., Boston Scientific
Corporation, Urologix, LLC., Karl Storz GmbH
Co. KG, Lumenis Ltd., Olympus Corporation, Advin
Urology, Convergent Laser Technologies, Richard
Wolf GmbH, Medtronic Plc.
8
Benign Prostatic Hyperplasia (BPH) Procedures
Download report sample at
https//www.psmarketresearch.com/market-analysis/b
enign-prostatic-hyperplasia-procedures/report-samp
le
9
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886